Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.1.6 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc-fda/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition f0f3ff35-5cfa-6617-b8f1-b8167957f53c
identifier: ASPIRIN-ACETAMINOPHEN-Identification
combinedPharmaceuticalDoseForm: TABLET, MULTILAYER
route: ORAL
comprisedOf: Bundle: identifier = UUID:49d3b79e-b436-a242-93ba-b706b4364ab2; type = document; timestamp = 2024-08-29 12:34:56+0000
name
productName: ASPIRIN 200mg, ACETAMINOPHEN 300mg
type: Non-Proprietary
part
part: ASPIRIN
type: scientific name
part
part: 200mg
type: ASPIRIN
part
part: ACETAMINOPHEN
type: scientific name
part
part: 300mg
type: ACETAMINOPHEN